A detailed history of Rockefeller Capital Management L.P. transactions in Codexis, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,000 shares of CDXS stock, worth $1,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$1,650
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$2.35 - $3.33 $2,350 - $3,330
1,000 New
1,000 $2,000
Q4 2022

Mar 06, 2023

SELL
$4.26 - $6.84 $426 - $684
-100 Reduced 9.09%
1,000 $4,000
Q3 2020

Nov 13, 2020

BUY
$11.21 - $13.82 $1,121 - $1,382
100 Added 10.0%
1,100 $12,000
Q3 2019

Nov 12, 2019

BUY
$12.75 - $19.01 $12,750 - $19,010
1,000 New
1,000 $14,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $108M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.